2-methyl-5-ht has been researched along with 1-methyl-d-lysergic acid butanolamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderó, JM; del Río, J; García, E; Lasheras, B; Monge, A; Palop, JA; Peña, MC; Roca, J; Romero, G | 1 |
| Butini, S; Caccia, S; Cagnotto, A; Campiani, G; Cervo, L; Dalla Valle, F; Fracasso, C; Gemma, S; Goegan, M; Greco, G; Hamon, M; Mennini, T; Morelli, E; Nacci, V; Novellino, E | 1 |
2 other study(ies) available for 2-methyl-5-ht and 1-methyl-d-lysergic acid butanolamide
| Article | Year |
|---|---|
Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
Topics: Animals; Benzothiazoles; Binding, Competitive; Cerebral Cortex; Female; Gastric Emptying; Granisetron; Guinea Pigs; Ileum; Male; Molecular Structure; Mucous Membrane; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 1994 |
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
Topics: Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Guanidine; Guinea Pigs; Hybrid Cells; In Vitro Techniques; Ligands; Male; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |